Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World

Cancer Cell Metastasis Prevention: Restoring Order

October 3, 2025 Jennifer Chen Health
News Context
At a glance
  • A new study led by Weill Cornell Medicine suggests ⁤a surprising approach to combatting triple ⁢negative breast cancer (TNBC), one ‍of the most aggressive and challenging-to-treat forms of...
  • Metastasis - the spread⁣ of cancer cells to distant parts of the body - is the ‍primary ‍reason for the poor survival rates associated with TNBC.
  • "Metastasis is the main reason patients with triple negative breast cancer face poor survival odds," said senior author Dr.
Original source: news.weill.cornell.edu

Okay,here’s a draft article‍ based on the provided text,adhering to⁢ all the specified requirements. It’s designed to be ‍informative, authoritative, and Google News-friendly. I’ve included all the required components and ⁢formatting.

“`html





Blocking EZH2 enzyme Shows⁣ Promise in Stopping Aggressive Triple Negative Breast Cancer ⁣Spread


blocking EZH2 ⁢Enzyme Shows Promise ⁢in ⁣Stopping Aggressive Triple negative Breast ‍Cancer Spread

A new study led by Weill Cornell Medicine suggests ⁤a surprising approach to combatting triple ⁢negative breast cancer (TNBC), one ‍of the most aggressive and challenging-to-treat forms of the disease. Researchers have discovered‍ that ⁣an enzyme called EZH2 plays a critical role in driving TNBC cell division and subsequent spread to ⁢other organs. preclinical findings indicate that drugs blocking EZH2 could restore normal cell division and prevent metastasis.

What: Researchers identified the EZH2 enzyme as a key driver of metastasis in triple negative breast ⁢cancer.
⁣
Where: The study was conducted at Weill Cornell Medicine, with co-leadership from⁤ Memorial Sloan Kettering Cancer Center.
When: Findings were published October 2, 2024, in Cancer Finding.
⁢
Why it Matters: This research challenges conventional treatment strategies and suggests a new therapeutic avenue for TNBC, perhaps improving survival rates.
‍
What’s Next: Further research is needed to develop and test EZH2-blocking drugs in clinical trials.

The Challenge of ⁣Triple Negative Breast Cancer

Metastasis – the spread⁣ of cancer cells to distant parts of the body – is the ‍primary ‍reason for the poor survival rates associated with TNBC. Unlike other breast cancers, TNBC lacks the presence of estrogen and progesterone receptors and‍ doesn’t overexpress the HER2 protein, limiting treatment options. This makes it⁢ especially challenging to treat.

“Metastasis is the main reason patients with triple negative breast cancer face poor survival odds,” said senior author Dr. Vivek⁣ Mittal, Ford-Isom Research ⁣Professor of⁣ Cardiothoracic Surgery⁤ and member of‍ the ⁢Sandra and Edward Meyer Cancer ⁣Center at Weill Cornell Medicine.‍ “Our study suggests a new therapeutic approach to block ⁤metastasis before it starts and help patients‍ overcome this deadly cancer.”

Dr. Vivek Mittal

Dr. Vivek Mittal

Challenging Conventional Wisdom

The

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Keep reading

  • Australia Warns of Rising H5N1 Bird Flu Outbreak Following Mass Bird Deaths
  • RSV Immunization: Protecting Newborns During the Golden Prenatal Period

Related

Search:

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.
For contact, advertising, copyright, issues email: office@newsdirectory3.com